Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
11.70
0.17 (1.47%)
At close: Jun 16, 2025, 3:59 PM

Stoke Therapeutics Revenue

Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending March 31, 2025, Stoke Therapeutics generated $158.57M in revenue.
Revenue (ttm)
$36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
$285.59K
Employees
128
Market Cap
638.78M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.